Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
13F holders, Q4 2025
Institutional positions in Clearside Biomedical, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CLSD is no longer listed, and 13F filings after Q3 2025 list far fewer holders. See Q3 2025
- Institutional holders
- 1
- −25 vs. Q3 2025
- Shares held
- 27.1K
- −525.3K (−95.1%) vs. Q3 2025
- Total value
- $19.1K
- −$2.17M (−99.1%) vs. Q3 2025
- New holders
- 1
- 0 more added
- Sold out
- 26
- 0 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLSD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $3.26K |
| Q1 2026 | 1 | $7.87K |
| Q4 2025 | 1 | $19.1K |
| Q3 2025 | 26 | $2.18M |
| Q2 2025 | 45 | $7.51M |
| Q1 2025 | 44 | $8.09M |
| Q4 2024 | 44 | $8.97M |
| Q3 2024 | 49 | $12.7M |
| Q2 2024 | 49 | $17.9M |
| Q1 2024 | 52 | $23.8M |
| Q4 2023 | 48 | $9.06M |
| Q3 2023 | 46 | $6.82M |
| Q2 2023 | 54 | $9.62M |
| Q1 2023 | 51 | $9.09M |
| Q4 2022 | 53 | $10.2M |
| Q3 2022 | 54 | $13.6M |
| Q2 2022 | 53 | $20.1M |
| Q1 2022 | 60 | $37.5M |
| Q4 2021 | 67 | $57.8M |
| Q3 2021 | 66 | $121.5M |
| Q2 2021 | 53 | $95.8M |
| Q1 2021 | 52 | $43.8M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Clearside Biomedical, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DRW Securities, LLC | 27,136 | $19.1K | 0.00% | +27,136 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −221,968−100.0% | Sold out |
| Carmignac Gestion | 0 | $0 | 0.00% | −100,556−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −52,741−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −41,677−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −25,247−100.0% | Sold out |
| Apollon Wealth Management, LLC | 0 | $0 | 0.00% | −23,586−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −22,846−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −16,387−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −12,885−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −11,032−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −9,303−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −7,194−100.0% | Sold out |
| New Millennium Group LLC | 0 | $0 | 0.00% | −2,952−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −118−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Financial Consulate, Inc | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |